Variant report
Variant | esv3418000 |
---|---|
Chromosome Location | chr22:23731015-23731436 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CES5AP1 | TF binding region |
ENSG00000248409 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540936676 | chr22:23731016-23731017 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529532063 | chr22:23731017-23731018 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532735814 | chr22:23731041-23731042 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373705271 | chr22:23731045-23731046 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552523547 | chr22:23731074-23731075 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs111401008 | chr22:23731090-23731091 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs73392651 | chr22:23731093-23731094 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs543691163 | chr22:23731100-23731101 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs113275309 | chr22:23731132-23731133 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs58355530 | chr22:23731138-23731139 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs56899354 | chr22:23731139-23731140 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs112031867 | chr22:23731142-23731143 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs557063301 | chr22:23731143-23731144 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs111387396 | chr22:23731145-23731146 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs61407799 | chr22:23731148-23731149 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs187032594 | chr22:23731149-23731150 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs531708522 | chr22:23731157-23731158 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs12483933 | chr22:23731168-23731169 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs56782634 | chr22:23731181-23731182 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs59582068 | chr22:23731182-23731183 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs112603077 | chr22:23731186-23731187 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs397964286 | chr22:23731190-23731191 | Weak transcription Enhancers Genic enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs565536984 | chr22:23731209-23731210 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs113720886 | chr22:23731210-23731211 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs113966259 | chr22:23731224-23731225 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs144362855 | chr22:23731228-23731229 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs80223404 | chr22:23731252-23731253 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | mRNA abundance |
28 | rs77181277 | chr22:23731257-23731258 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs373774798 | chr22:23731259-23731260 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs71200854 | chr22:23731264-23731265 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs11090241 | chr22:23731276-23731277 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | mRNA abundance |
32 | rs573058472 | chr22:23731280-23731281 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs13058103 | chr22:23731281-23731282 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs540575293 | chr22:23731294-23731295 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs189167984 | chr22:23731295-23731296 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs35667903 | chr22:23731300-23731301 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs13057313 | chr22:23731308-23731309 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs532420562 | chr22:23731313-23731314 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs11090242 | chr22:23731319-23731320 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs11090243 | chr22:23731324-23731325 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs576174987 | chr22:23731327-23731328 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs535545626 | chr22:23731337-23731338 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs375896570 | chr22:23731338-23731339 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs572059407 | chr22:23731360-23731361 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs540715999 | chr22:23731361-23731362 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs560816269 | chr22:23731363-23731364 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs5759763 | chr22:23731367-23731368 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs546343008 | chr22:23731368-23731369 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs111358945 | chr22:23731381-23731382 | Weak transcription Enhancers Genic enhancers Bivalent Enhancer | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs533700480 | chr22:23731402-23731403 | Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 17989066 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Li-fraumeni syndrome | 18685109 | CNVD |
Breast cancer | 20409316 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Cancer | 19424424 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23725400-23736800 | Weak transcription | Fetal Brain Female | brain |
2 | chr22:23726400-23734600 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr22:23726600-23731400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr22:23726800-23731400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr22:23726800-23733200 | Weak transcription | Lung | lung |
6 | chr22:23726800-23739400 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr22:23726800-23744200 | Weak transcription | Brain Anterior Caudate | brain |
8 | chr22:23727400-23731200 | Weak transcription | Fetal Intestine Small | intestine |
9 | chr22:23728200-23731400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr22:23728600-23733800 | Weak transcription | Ovary | ovary |
11 | chr22:23728600-23744200 | Weak transcription | Brain Angular Gyrus | brain |
12 | chr22:23728600-23744200 | Weak transcription | Brain Hippocampus Middle | brain |
13 | chr22:23728800-23738400 | Weak transcription | Fetal Thymus | thymus |
14 | chr22:23730000-23731600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr22:23730200-23731800 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr22:23730400-23731600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr22:23730400-23733800 | Weak transcription | Brain Germinal Matrix | brain |
18 | chr22:23730800-23731400 | Enhancers | HepG2 | liver |
19 | chr22:23730800-23731600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
20 | chr22:23730800-23732000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr22:23731000-23733200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
22 | chr22:23731200-23731800 | Enhancers | Fetal Intestine Small | intestine |
23 | chr22:23731200-23732000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
24 | chr22:23731200-23732200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
25 | chr22:23731400-23731600 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
26 | chr22:23731400-23731800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
27 | chr22:23731400-23732000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
28 | chr22:23731400-23732000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
29 | chr22:23731400-23732000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
30 | chr22:23731400-23732000 | Enhancers | Fetal Intestine Large | intestine |
31 | chr22:23731400-23732000 | Flanking Active TSS | HepG2 | liver |